A federal waiver helped give rise to a new industry treating depression with the psychedelic drug ketamine by telemedicine. Now the controversial approach faces an uncertain future.
A federal waiver helped give rise to a new industry treating depression with the psychedelic drug ketamine by telemedicine. Now the controversial approach faces an uncertain future.